Althea Completes New Biologics Facility

Althea Technologies, Inc. has opened its new commercial-scale cGMP manufacturing facility in San Diego, CA. The new facility provides additional capacity and expands the company’s services from early clinical development through Phase III and commercial supply.

“We are very excited to launch our 30,000-sq.-ft. commercial-scale cGMP manufacturing facility because it allows Althea Technologies to take an integrated approach in the manufacturing of exciting new biotechnology-derived therapies. The completion of this building marks a significant milestone in our ultimate goal of accelerating the development and delivery of novel therapies to the people who need them most,” stated Dr. Magda Marquet, co-chairman and founder.

The cGMP facility complies with both U.S. and European manufacturing regulations and according to the company, the building management system ensures a sterile manufacturing environment.

“The commercial expansion will enable Althea to contribute to the economic vitality of the region through the addition of personnel and the ability to help ensure the continued success of more biotech companies,” said Dr. Franxcois Ferre, co-chairman and founder of Althea Technologies.